M&C Saatchi revenues hit by US government shutdown while S4 Capital blames 'lower project-based revenue and continued client caution'.

Next year, average enrollee premium payments in the FEHB system are set to jump more than 12%, on top of a 13.5% hike in 2025.

AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) was approved in the U.S. for the treatment of adult ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana ‘s surgeon general, has been ...

U.S. set to unveil 15 new Medicare-negotiated drug prices; U.S.-U.K. drug pricing deal could be unveiled; Louisiana surgeon general tapped as deputy director at CDC.

The FDA issued a letter to Incyte on November 20 indicating that the drugmaker addressed the violations contained in an Untitled Letter it received in September.

Fighting invasive oral cancer at age 51 forced Sonya Sotinsky to confront the existential importance of the human voice.

Officials have deemed terms like “immunizations” and “vaccines” risky “buzzwords” that require approval to be used in social media posts, pamphlets and presentations.

Biopharmaceutical company Gilead Sciences has hired Bob Allen as head of omnichannel strategy and digital transformation for public affairs.

During the incipient days of computing, DOS, or Disk Operating System, did more than just power the machines; it defined how the machines worked. It was the essential, unifying language that allowed ...

Novo misses in Alzheimer's trial; Insurer shares rise on report Trump will unveil health policy proposal; Bayer’s stroke drug succeeds in late-stage trial.

Calling him a “tremendous” health advocate, DeMyers adds that leveraging Davis to get the word out about TD will help more people start conversations with their doctors about the condition. Going ...